$CG 3 SEC Filings

Filed On	Filing
08 Jul 2026	Form 3: Heinzelman Kate Elizabeth, General Counsel No securities owned
09 Jan 2026	Form 3: Nedelman Jeffrey, Co-President Holds 1,499,881 shares of Common Stock
09 Jan 2026	Form 3: Jenkins Mark David, Co-President Holds 1,414,484 shares of Common Stock
09 Jan 2026	Form 3: Plouffe Justin, Chief Financial Officer Holds 902,211 shares of Common Stock
17 Dec 2025	Form 3: Carlyle Group Inc., 10% owner and 6 others · Medline Inc. Holds 158,245,640 shares of Class A Common Stock
02 Oct 2024	Form 3: Carlyle Group Inc., 10% owner and 9 others · StandardAero, Inc. Holds 223,039,914 shares of Common Stock
11 Jul 2024	Form 3: Carlyle Group Inc., 10% owner and 6 others · SunPower Inc
01 Jul 2024	Form 3: LoBue Lindsay, Chief Operating Officer Holds 126,012 shares of Common Stock
02 May 2024	Form 3: Beschloss Afsaneh Mashayekhi, Director No securities owned
02 Oct 2023	Form 3: Redett John C., Chief Financial Officer Holds 37,593 shares of Common Stock
05 Jun 2023	Form 3: Cherwoo Sharda, Director No securities owned
17 Feb 2023	Form 3: Schwartz Harvey M, Director No securities owned
23 Jan 2023	Form 3: Carlyle Global Credit Investment Management L.l.c., 10% owner and 7 others · Carlyle Credit Income Fund Holds 0 shares of Shares of Beneficial Interest
29 Aug 2022	Form 3: Carlyle Group Inc., 10% owner and 7 others · MKS Incorporated Holds 8,482,732 shares of Common Stock
11 Aug 2022	Form 3: Carlyle Group Inc., 10% owner and 7 others · eFFECTOR Therapeutics, Inc. Holds 4,822,114 shares of Common Stock
11 Aug 2022	Form 3: Carlyle Group Inc., 10% owner and 7 others · Jasper Therapeutics, Inc. Holds 5,628,558 shares of Voting Common Stock
11 Aug 2022	Form 3: Carlyle Group Inc., 10% owner and 7 others · SOLENO THERAPEUTICS INC Holds 18,022,602 shares of Common Stock
11 Aug 2022	Form 3: Carlyle Group Inc., 10% owner and 7 others · Vera Therapeutics, Inc. Holds 2,960,231 shares of Class A Common Stock
06 Jun 2022	Form 3: Carlyle Group Inc., 10% owner and 8 others · QuidelOrtho Corp Holds 12,460,183 shares of Common Stock
08 Apr 2022	Form 3: Hefner Linda P, Director No securities owned

Comments